+91 8483 9659 21 (APAC)

+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)

sales@researchlayer.com

Global Drug Delivery Devices Market Research Report: Information By Application (Cardiovascular, Diabetes, Cancer, Infectious Diseases, and Others), By Route of Administration (Oral, Ocular, Inhalation, Nasal, Injectable, Topical, and Others), By End User(Hospitals, Ambulatory Services, and Home Healthcare), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) –Market Forecast Till 2032.

  •  Region : Global
  • Chemicals and Material
  • Published Report
  • Aug 2023
  •  Pages : 300
  •  Format : PDF/Excel
  •  Report ID : RL6574

Table of Contents:

1.    Executive summary

2.    Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1.  Research Objective

2.2.2.  Assumptions

2.2.3.  Limitations         

3.    Research Methodology

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1.         Primary Interviews and Information Gathering Process

3.4.2.         Breakdown of Primary Respondents  

3.5. Forecasting Modality

3.6. Market Size Estimation

3.6.1.         Bottom-Up Approach

3.6.2.         Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4.    Market Dynamics

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5.    Market Factor Analysis

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1.  Bargaining Power of Suppliers

5.2.2.  Bargaining Power of Buyers

5.2.3.  Threat of New Entrants

5.2.4.  Threat of Substitutes

5.2.5.  Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1.  Market Impact Analysis

5.3.2.  Regional Impact

5.3.3.  Opportunity and Threat Analysis

6.    GLOBAL Drug Delivery Devices MARKET, BY Route of Administration

6.1. Overview

6.2. Oral

6.3. Ocular

6.4. Inhalation

6.5. Nasal

6.6. Injectable

6.7. Topical

6.8. Others

7.    GLOBAL Drug Delivery Devices MARKET, BY Application

7.1. Overview

7.2. Cardiovascular

7.3. Diabetes

7.4. Cancer

7.5. Infectious Diseases

7.6. Others 

8.    GLOBAL Drug Delivery Devices MARKET, BY END-USER

8.1. Overview

8.2. Hospitals

8.3. Ambulatory Services

8.4. Home Healthcare

9.    GLOBAL Drug Delivery Devices MARKET, by Region

9.1. Overview

9.2. North America

9.2.1.         U.S.

9.2.2.         Canada

9.3. Europe

9.3.1.         Germany

9.3.2.         France

9.3.3.         U.K

9.3.4.         Italy

9.3.5.         Spain

9.3.6.         Rest of Europe

9.4. Asia-Pacific

9.4.1.         China

9.4.2.         India

9.4.3.         Japan

9.4.4.         South Korea

9.4.5.         Australia

9.4.6.         Rest of Asia-Pacific

9.5. Rest of the World

9.5.1.         Middle East

9.5.2.         Africa

9.5.3.         Latin America

10. Competitive Landscape

10.1. Overview         

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Drug Delivery Devices Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Drug Delivery Devices Market,

10.7. Key developments and Growth Strategies

10.7.1.                      New Route of Administration Launch/Application Deployment

10.7.2.                      Merger & Acquisitions

10.7.3.                      Joint Ventures

10.8. Major Players Financial Matrix

10.8.1.      Sales & Operating Income, 2022

10.8.2.      Major Players R&D Expenditure. 2022

11. Company ProfileS

11.1. Pfizer, Inc.

11.1.1.                      Company Overview

11.1.2.                      Financial Overview

11.1.3.                      Route of Administrations Offered

11.1.4.                      Key Developments

11.1.5.                      SWOT Analysis

11.1.6.                      Key Strategies

11.2. Hoffmann-La Roche Ltd

11.2.1.                      Company Overview

11.2.2.                      Financial Overview

11.2.3.                      Route of Administrations Offered

11.2.4.                      Key Developments

11.2.5.                      SWOT Analysis

11.2.6.                      Key Strategies

11.3. Johnson and Johnson Private Ltd

11.3.1.                      Company Overview

11.3.2.                      Financial Overview

11.3.3.                      Route of Administrations Offered

11.3.4.                      Key Developments

11.3.5.                      SWOT Analysis

11.3.6.                      Key Strategies

11.4. Novartis AG

11.4.1.                      Company Overview

11.4.2.                      Financial Overview

11.4.3.                      Route of Administrations Offered

11.4.4.                      Key Developments

11.4.5.                      SWOT Analysis

11.4.6.                      Key Strategies

11.5. Bayer AG

11.5.1.                      Company Overview

11.5.2.                      Financial Overview

11.5.3.                      Route of Administrations Offered

11.5.4.                      Key Developments

11.5.5.                      SWOT Analysis

11.5.6.                      Key Strategies

11.6. BECTON

11.6.1.                      Company Overview

11.6.2.                      Financial Overview

11.6.3.                      Route of Administrations Offered

11.6.4.                      Key Developments

11.6.5.                      SWOT Analysis

11.6.6.                      Key Strategies

11.7. Dickinson and Company

11.7.1.                      Company Overview

11.7.2.                      Financial Overview

11.7.3.                      Route of Administrations Offered

11.7.4.                      Key Developments

11.7.5.                      SWOT Analysis

11.7.6.                      Key Strategies

11.8. Uniqure NV

11.8.1.                      Company Overview

11.8.2.                      Financial Overview

11.8.3.                      Route of Administrations Offered

11.8.4.                      Key Developments

11.8.5.                      SWOT Analysis

11.8.6.                      Key Strategies

12. Appendix

12.1. References

12.2. Related Reports

 

 

LIST OF TABLES

TABLE 1                 Global Drug Delivery Devices Market, Synopsis, 2018-2032

TABLE 2                 Global Drug Delivery Devices Market, Estimates & Forecast, 2018-2032 (USD BILLION)

TABLE 3                 GLOBAL Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 4                 GLOBAL Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5                 GLOBAL Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 6                 North America Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 7                 North America Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 8                 North America Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 9                 North America Drug Delivery Devices MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 10             U.S. Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 11             U.S. Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 12             U.S. Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 13             Canada Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 14             Canada Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 15             Canada Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 16             Europe Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 17             Europe Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 18             Europe Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 19             Europe Drug Delivery Devices MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 20             Germany Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 21             Germany Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 22             Germany Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 23             France Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 24             France Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 25             France Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 26             Italy Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 27             Italy Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 28             Italy Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 29             Spain Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 30             Spain Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 31             Spain Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 32             U.K Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 33             U.K Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 34             U.K Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 35             Rest of Europe Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 36             Rest of Europe Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 37             Rest of Europe Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 38             Asia Pacific Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 39             Asia Pacific Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 40             Asia Pacific Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 41             Asia Pacific Drug Delivery Devices MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 42             Japan Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 43             Japan Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 44             Japan Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 45             China Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 46             China Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 47             China Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 48             India Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 49             India Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 50             India Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 51             Australia Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 52             Australia Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 53             Australia Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 54             south korea Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 55             south korea Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 56             south korea Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 57             Rest of asia-pacific Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 58             Rest of asia-pacific Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 59             Rest of asia-pacific Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 60             Rest of WOrld Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 61             Rest of WOrld Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 62             Rest of WOrld Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 63             Rest of WOrld Drug Delivery Devices MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 64             Middle east Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 65             Middle east Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 66             Middle east Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 67             Africa Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 68             Africa Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 69             Africa Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 70             Latin america Drug Delivery Devices MARKET, BY Route of Administration, 2018-2032 (USD BILLION)

TABLE 71             Latin america Drug Delivery Devices MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 72             Latin america Drug Delivery Devices MARKET, BY END-USER, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1             Research Process

FIGURE 2             Market Structure for the Global Drug Delivery Devices Market

FIGURE 3             Market Dynamics for the Global Drug Delivery Devices Market

FIGURE 4             Global Drug Delivery Devices Market, Share (%), BY Route of Administration, 2022

FIGURE 5             Global Drug Delivery Devices Market, Share (%), BY APPLICATION, 2022

FIGURE 6             Global Drug Delivery Devices Market, Share (%), BY END-USER, 2022

FIGURE 7             Global Drug Delivery Devices Market, Share  (%), by Region, 2022

FIGURE 8             north AMERICA: Drug Delivery Devices MARKET, SHARE (%), BY REGION, 2022

FIGURE 9             Europe: Drug Delivery Devices MARKET, SHARE (%), BY REGION, 2022

FIGURE 10         Asia-Pacific: Drug Delivery Devices MARKET, SHARE  (%), BY REGION, 2022

FIGURE 11         Rest of the world: Drug Delivery Devices MARKET, SHARE (%), BY REGION, 2022

FIGURE 12         Global Drug Delivery Devices Market: Company Share Analysis, 2022 (%)

FIGURE 13         Pfizer, Inc.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14         Pfizer, Inc.: SWOT ANALYSIS

FIGURE 15         Hoffmann-La Roche Ltd: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16         Hoffmann-La Roche Ltd: SWOT ANALYSIS

FIGURE 17         Johnson and Johnson Private Ltd: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18         Johnson and Johnson Private Ltd: SWOT ANALYSIS

FIGURE 19         Novartis AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20         Novartis AG: SWOT ANALYSIS

FIGURE 21         Bayer AG.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22         Bayer AG.: SWOT ANALYSIS

FIGURE 23         BECTON: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24         BECTON: SWOT ANALYSIS

FIGURE 25         Dickinson and Company: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26         Dickinson and Company: SWOT ANALYSIS

FIGURE 27         Uniqure NV: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28         Uniqure NV: SWOT ANALYSIS

 

 

Global Drug Delivery Devices Market Research Report: Information By Application (Cardiovascular, Diabetes, Cancer, Infectious Diseases, and Others), By Route of Administration (Oral, Ocular, Inhalation, Nasal, Injectable, Topical, and Others), By End User(Hospitals, Ambulatory Services, and Home Healthcare), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) –Market Forecast Till 2032.  

Report Code :
RL6574
Published on :
Aug 2023

Request a Free Sample Report


CHOOSE LICENCE TYPE
  • :   $3749   
  • :   $5549   
  • :   $7549   

Latest Reports
Press Release

PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your format and defination
  • Gain Deeper Dive on a Specific Application,Geography,Customer or Computer
  • Any Level of Personalization
  • Why Choose Us
       

    Our Clients

    electronic and semiconductor      electronic and semiconductor      C2C      electronic and semiconductor      electronic and semiconductor      electronic and semiconductor      SELENIS       electronic and semiconductor            electronic and semiconductor      electronic and semiconductor      electronic and semiconductor      electronic and semiconductor       mips protection       Opulent International       SELENIS       inkuy       MIVV      GSPANN      ANI CO., LTD      C2C      C2C      C2C      C2C      C2C